Format

Send to

Choose Destination
Oral Oncol. 2016 Mar;54:1-6. doi: 10.1016/j.oraloncology.2015.12.007. Epub 2016 Jan 7.

The role of autophagy in squamous cell carcinoma of the head and neck.

Author information

1
Institute for Cellular Medicine, Newcastle University, United Kingdom. Electronic address: Benjamin.Cosway@Newcastle.ac.uk.
2
Institute for Cellular Medicine, Newcastle University, United Kingdom.

Abstract

Half a million new head and neck cancers are diagnosed each year worldwide. Although traditionally thought to be triggered by alcohol and smoking abuse, there is a growing subset of oropharyngeal cancers driven by the oncogenic human papilloma virus (HPV). Despite advances in both surgical and non-surgical treatment strategies, survival rates have remained relatively static emphasising the need for novel therapeutic approaches. Autophagy, the principal catabolic process for the lysosomal--mediated breakdown of cellular products is a hot topic in cancer medicine. Increasing evidence points towards the prognostic significance of autophagy biomarkers in solid tumours as well as strategies through which to harness autophagy modulation to promote tumour cell death. However, the role of autophagy in head and neck cancers is less well defined. In the present review, we summarise the current understanding of autophagy in head and neck cancers, revealing key areas for future translational research.

KEYWORDS:

Antineoplastic protocols; Autophagy; Biological markers; Head and neck neoplasms

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center